Compare XAIR & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XAIR | SSKN |
|---|---|---|
| Founded | 2011 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5M | 8.9M |
| IPO Year | N/A | 2005 |
| Metric | XAIR | SSKN |
|---|---|---|
| Price | $0.94 | $1.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $11.00 | $6.00 |
| AVG Volume (30 Days) | ★ 118.3K | 70.1K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $5,802,000.00 | ★ $30,980,000.00 |
| Revenue This Year | $128.45 | N/A |
| Revenue Next Year | $153.25 | $7.74 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 147.74 | N/A |
| 52 Week Low | $0.90 | $1.23 |
| 52 Week High | $11.20 | $3.86 |
| Indicator | XAIR | SSKN |
|---|---|---|
| Relative Strength Index (RSI) | 28.95 | 36.39 |
| Support Level | $0.91 | $1.29 |
| Resistance Level | $1.31 | $1.37 |
| Average True Range (ATR) | 0.09 | 0.08 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 11.36 | 7.91 |
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.